Beckman Daniella
SEC insider (Form 3/4/5 filer). CIK 0001513422. Director at Vor Biopharma Inc. (VOR) and 3 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in WALTHAM, MA.
Companies Beckman Daniella has filed insider reports for
- Vor Biopharma Inc. (VOR): Director
- Upstream Bio, Inc. (UPB): Director
- Tango Therapeutics, Inc. (TNGX): Officer, Chief Financial Officer
- Blueprint Medicines Corp (BPMC): Director
Beckman Daniella
CIK: 0001513422
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 11, 2026VOR
Vor Biopharma Inc.
AwardDirectStock option (right to buy)
53.3K shares- - Jun 9, 2026UPB
Upstream Bio, Inc.
AwardDirectStock Option (Right to Buy)
17.1K shares- - Feb 3, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect10.2K shares at avg. $12.26$125K - Feb 3, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect113 shares at avg. $12.90$1K - Feb 2, 2026TNGX
Tango Therapeutics, Inc.
AwardDirect44.3K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
DispositionDirect3.9K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
Tender OfferDirect10.8K shares- - Jun 18, 2025BPMC
Blueprint Medicines Corp
AwardDirect3.9K shares at avg. $128.12$500K - Jun 10, 2025UPB
Upstream Bio, Inc.
AwardDirectStock Option (Right to Buy)
17.1K shares- - May 22, 2025VOR
Vor Biopharma Inc.
AwardDirectStock Option (Right to Buy)
30K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  VOR Vor Biopharma Inc. | Award Stock option (right to buy) | 53,283 | - | - | Direct |
| Jun 9, 2026 |  UPB Upstream Bio, Inc. | Award Stock Option (Right to Buy) | 17,096 | - | - | Direct |
| Feb 3, 2026 |  TNGX Tango Therapeutics, Inc. | Sale | 10,204 | $12.26 | $125,073 | Direct |
| Feb 3, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 113 | $12.90 | $1,457 | Direct |
| Feb 2, 2026 | TNGX Tango Therapeutics, Inc. | Award | 44,330 | - | $0 | Direct |
| Jul 17, 2025 |  BPMC Blueprint Medicines Corp | Disposition | 3,902 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Tender Offer | 10,842 | - | - | Direct |
| Jun 18, 2025 | BPMC Blueprint Medicines Corp | Award | 3,902 | $128.12 | $499,924 | Direct |
| Jun 10, 2025 | UPB Upstream Bio, Inc. | Award Stock Option (Right to Buy) | 17,096 | - | - | Direct |
| May 22, 2025 | VOR Vor Biopharma Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
1-10 of 14 transactions